Journal of Microbiology and Biotechnology

  • 제34권8호
  • /
  • Pages.1711-1717
  • /
  • 2024
  • /
  • 1017-7825(pISSN)
  • /
  • 1738-8872(eISSN)
한국미생물·생명공학회 (The Korean Society for Microbiology and Biotechnology)
권호 표지
DOI QR코드

DOI QR Code

Harnessing Decellularized Extracellular Matrix for Enhanced Fidelity in Colorectal Cancer Organoid and Cell-Derived Xenograft Models

  • Yena Nam (Department of Physiology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine) ;
  • Eunju Cha (Department of Physiology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine) ;
  • Su Min Kwak (Department of Medicine, College of Medicine, Yonsei University Graduate School) ;
  • Seung Ju Seo (Department of Physiology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine) ;
  • John Hoon Rim (Department of Laboratory Medicine, Yonsei University College of Medicine) ;
  • Yoonhee Jin (Department of Physiology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine)
  • 투고 : 2024.05.30
  • 심사 : 2024.06.14
  • 발행 : 2024.08.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

This study evaluates the efficacy of a decellularized intestine tissue-derived extracellular matrix (Intestine ECM) as a scaffold for culturing colorectal cancer (CRC) organoids and establishing cell-derived xenograft (CDX) models, comparing its performance to traditional Matrigel. Intestine ECM demonstrates comparable support for organoid formation and cellular function, highlighting its potential as a more physiologically relevant and reproducible platform. Our findings suggest that Intestine ECM enhances the mimetic environment for colon epithelium, supporting comparable growth and improved differentiation compared to Matrigel. Moreover, when used as a delivery carrier, Intestine ECM significantly increases the growth rate of CDX models using patient-derived primary colorectal cancer cells. This enhancement demonstrates Intestine ECM's role not only as a scaffold but also as a vital component of the tumor microenvironment, facilitating more robust tumorigenesis. These findings advocate for the broader application of Intestine ECM in cancer model systems, potentially leading to more accurate preclinical evaluations and the development of targeted cancer therapies.

키워드

과제정보

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2021R1C1C2009131, No. 2022R1A2C1013380) and the Bio & Medical Technology Development Program of the NRF & funded by the Korean government (MSIT) (No. 2022M3A9B6082675). This work also supported by a grant (20024298) from the Technology Innovation Program funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea).

참고문헌

  1. Fatehullah A, Tan SH, Barker N. 2016. Organoids as an in vitro model of human development and disease. Nat. Cell. Biol. 18: 246-254. https://doi.org/10.1038/ncb3312
  2. Lancaster MA, Knoblich JA. 2014. Organogenesis in a dish: modeling development and disease using organoid technologies. Science 345: 1247125.
  3. Liu Y, Wu W, Cai C, Zhang H, Shen H, Han Y. 2023. Patient-derived xenograft models in cancer therapy: technologies and applications. Signal Transduct. Target. Ther. 8: 160.
  4. Cho SY, Kang W, Han JY, Min S, Kang J, Lee A, et al. 2016. An integrative approach to precision cancer medicine using patient-derived xenografts. Mol. Cells 39: 77-86. https://doi.org/10.14348/molcells.2016.2350
  5. Jung YH, Park K, Kim M, Oh H, Choi DH, Ahn J, et al. 2023. Development of an extracellular matrix plate for drug screening using patient-derived tumor organoids. Biochip. J. 17: 284-292.
  6. Fujii M, Shimokawa M, Date S, Takano A, Matano M, Nanki K, et al. 2016. A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis. Cell Stem Cell 18: 827-838 https://doi.org/10.1016/j.stem.2016.04.003
  7. Toshimitsu K, Takano A, Fujii M, Togasaki K, Matano M, Takahashi S, et al. 2022. Organoid screening reveals epigenetic vulnerabilities in human colorectal cancer. Nat. Chem. Biol. 18: 605-614 https://doi.org/10.1038/s41589-022-00984-x
  8. Nagle PW, Plukker JTM, Muijs CT, van Luijk P, Coppes RP. 2018. Patient-derived tumor organoids for prediction of cancer treatment response. Semin. Cancer Biol. 53: 258-264. https://doi.org/10.1016/j.semcancer.2018.06.005
  9. Heo JH, Kang D, Seo SJ, Jin Y. 2022. Engineering the extracellular matrix for organoid culture. Int. J. Stem Cells 15: 60-69. https://doi.org/10.15283/ijsc21190
  10. Jung P, Sato T, Merlos-Suarez A, Barriga FM, Iglesias M, Rossell D, et al. 2011. Isolation and in vitro expansion of human colonic stem cells. Nat. Med. 17: 1225-1227. https://doi.org/10.1038/nm.2470
  11. Sensi F, D'Angelo E, D'Aronco S, Molinaro R, Agostini M. 2018. Preclinical three-dimensional colorectal cancer model: the next generation of in vitro drug efficacy evaluation. J. Cell Physiol. 234: 181-191.
  12. Van De Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, Pronk A, et al. 2015. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161: 933-945. https://doi.org/10.1016/j.cell.2015.03.053
  13. Drost J, Clevers H. 2018. Organoids in cancer research. Nat. Rev. Cancer 18: 407-418. https://doi.org/10.1038/s41568-018-0007-6
  14. Zeki SS, Graham TA, Wright NA. 2011. Stem cells and their implications for colorectal cancer. Nat. Rev. Gastroenterol. Hepatol. 8: 90-100. https://doi.org/10.1038/nrgastro.2010.211
  15. Kleinman HK, Martin GR. 2005. Matrigel: basement membrane matrix with biological activity. Semin. Cancer Biol. 15: 378-386. https://doi.org/10.1016/j.semcancer.2005.05.004
  16. Hughes CS, Postovit LM, Lajoie GA. 2010. Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics 10: 1886-1890 https://doi.org/10.1002/pmic.200900758
  17. Yuan Z, Li Y, Zhang S, Wang X, Dou H, Yu X, et al. 2023. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Mol. Cancer 22: 48
  18. Varinelli L, Guaglio M, Brich S, Zanutto S, Belfiore A, Zanardi F, et al. 2022. Decellularized extracellular matrix as scaffold for cancer organoid cultures of colorectal peritoneal metastases. J. Mol. Cell Biol. 14: mjac064.
  19. Chen K, Xu M, Lu F, He Y. 2023. Development of matrix metalloproteinases-mediated extracellular matrix remodeling in regenerative medicine: a mini review. Tissue Eng. Regen. Med. 20: 661-670. https://doi.org/10.1007/s13770-023-00536-x
  20. Aisenbrey EA, Murphy WL. 2020. Synthetic alternatives to matrigel. Nat. Rev. Mater. 5: 539-551. https://doi.org/10.1038/s41578-020-0199-8
  21. Kim S, Min S, Choi YS, Jo SH, Jung JH, Han K, et al. 2022. Tissue extracellular matrix hydrogels as alternatives to matrigel for culturing gastrointestinal organoids. Nat. Commun. 13: 1692.
  22. Lam D, Enright HA, Cadena J, Peters SKG, Sales AP, Osburn JJ, et al. 2019. Tissue-specific extracellular matrix accelerates the formation of neural networks and communities in a neuron-glia co-culture on a multi-electrode array. Sci. Rep. 9: 4159
  23. Giobbe GG, Crowley C, Luni C, Campinoti S, Khedr M, Kretzschmar K, et al. 2019. Extracellular matrix hydrogel derived from decellularized tissues enables endodermal organoid culture. Nat. Commun. 10: 5658.
  24. Boj SF, Vonk AM, Statia M, Su J, Vries RRG, Beekman JM, et al. 2017. Forskolin-induced swelling in intestinal organoids: an in vitro assay for assessing drug response in cystic fibrosis patients. J. Vis. Exp. 2017: 55159.
  25. Dekkers JF, Wiegerinck CL, De Jonge HR, Bronsveld I, Janssens HM, De Winter-De Groot KM, et al. 2013. A functional CFTR assay using primary cystic fibrosis intestinal organoids. Nat. Med. 19: 939-945. https://doi.org/10.1038/nm.3201
  26. O'Rourke KP, Loizou E, Livshits G, Schatoff EM, Baslan T, Manchado E, et al. 2017. Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer. Nat. Biotechnol. 35: 577-582. https://doi.org/10.1038/nbt.3837
  27. Fang G, Lu H, Rodriguez de la Fuente L, Law AMK, Lin G, Jin D, et al. 2021. Mammary tumor organoid culture in non-adhesive alginate for luminal mechanics and high-throughput drug screening. Adv. Sci. (Weinh) 8: 2102418.
  28. Bacchi CE, Gown AM. 1991. Distribution and pattern of expression of villin, a gastrointestinal-associated cytoskeletal protein, in human carcinomas: a study employing paraffin-embedded tissue. Lab. Invest. 64: 418-424.
  29. Arango D, Al-Obaidi S, Williams DS, Dopeso H, Mazzolini R, Corner G, et al. 2012. Villin expression is frequently lost in poorly differentiated colon cancer. Am. J. Pathol. 180: 1509-1521. https://doi.org/10.1016/j.ajpath.2012.01.006
  30. Hsieh AL, Walton ZE, Altman BJ, Stine ZE, Dang C V. 2015. MYC and metabolism on the path to cancer. Semin. Cell Dev. Biol. 43: 11-21. https://doi.org/10.1016/j.semcdb.2015.08.003
  31. Dang C V. 2012. MYC on the path to cancer. Cell 149: 22-35. https://doi.org/10.1016/j.cell.2012.03.003
  32. Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, Hansen AS, Gouw AM, Felsher DW. 2022. The MYC oncogene - the grand orchestrator of cancer growth and immune evasion. Nat. Rev. Clin. Oncol. 19: 23-36. https://doi.org/10.1038/s41571-021-00549-2
  33. Cattaneo CM, Dijkstra KK, Fanchi LF, Kelderman S, Kaing S, van Rooij N, et al. 2020. Tumor organoid-T-cell coculture systems. Nat. Protoc. 15: 15-39. https://doi.org/10.1038/s41596-019-0232-9
  34. Dijkstra KK, Cattaneo CM, Weeber F, Chalabi M, van de Haar J, Fanchi LF, et al. 2018. Generation of tumor-reactive T cells by coculture of peripheral blood lymphocytes and tumor organoids. Cell 174: 1586-1598.e12. https://doi.org/10.1016/j.cell.2018.07.009